Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.
Press Enter ↵ to search evidence
Explore by Goal
"If you thought that science was certain - well, that is just an error on your part."
- Richard Feynman
Quick Explanation
Copied
Bottom line (evidence-first): Multiple recent human studies report blood-based molecular changes associated with long-term meditation or multimodal mind–body training — including gene-specific DNA methylation shifts in Alzheimer’s-related genes (ADAM10, ABCA7, APOE, HOXA3) and systemic neuroplasticity/oxidative-stress biomarkers (BDNF, cortisol, IL-6, SIRT1, ROS, telomerase) — but all studies have moderate sample sizes, design limitations (non-randomized or small RCT), blood-versus-brain inference limits, and possible confounding (lifestyle/healthy-user) that weaken causal claims and generalizability.
Visualize first: key numeric molecular endpoints extracted from the source studies (blood methylation % and biomarker means). Explanations follow each figure. All numeric claims are cited below each chart.
Figure notes: Values are taken from the proof-of-concept mindfulness methylation study. ADAM10 shows low absolute methylation percentages (~1–3%) but a clear relative increase in long-term meditators and further increase after a 1-month retreat; ABCA7 shows a small absolute decrease post-retreat; APOE and HOXA3 are high-percent methylation loci with small absolute differences. Small absolute differences at low-percentage CpGs can be biologically meaningful but are more sensitive to technical noise in pyrosequencing.
Figure notes: The randomized YMLI trial reported clinically meaningful symptom reduction and increases in BDNF (+5.48 ng/mL) and telomerase activity, and reductions in cortisol and IL‑6 versus control after 12 weeks. Effect sizes were substantial within this clinical sample, but the trial is single-center, not participant-blinded, and limited to MDD patients on medications, so generalizability is limited.
Figure notes: The Timeless Wisdom Training cohort (1.6 years) reported 3,227 differentially methylated CpGs (253 genes) using EPIC arrays — large in magnitude but requiring external replication, technical validation, and control for cellular-composition shifts. Data are not fully public due to sensitivity constraints.
Critical synthesis (evidence-weighted)
Consistency: Multiple independent human datasets (targeted pyrosequencing, EPIC arrays, and RCT blood biomarkers) indicate meditation/Yoga-based programs can associate with molecular changes in blood — ranging from gene-specific methylation to circulating protein/enzymatic biomarkers. Each report uses different assays/populations, so direct cross-study pooling is not yet possible (, ).
Size & biological plausibility: Some changes (e.g., BDNF increase in RCT) are large and biologically plausible for neuroplasticity signaling; methylation changes in blood are modest in absolute % and may not reflect neuronal methylation states — caution required when inferring brain-level protection ().
Study design risks: The strongest causal claim comes from the RCT (YMLI) but that trial is small and unblinded. The methylation proof-of-concept is controlled but non-randomized and small (N=34). The EPIC-array cohort is larger but observational/pilot and data access is restricted. Across these studies, common blindspots include healthy-user bias, lifestyle confounding (diet, exercise, sleep), cellular-composition changes in blood, batch effects, and multiple-testing risks in array data.
Reproducibility & open data: EPIC-array results are not openly available (sensitivity), limiting independent reanalysis; the pyrosequencing targeted results are more verifiable but small-N; raw data availability would substantially raise confidence.
How these findings could be disproved: (a) Large randomized controlled trials with blinded outcome assessment showing no biomarker changes; (b) brain tissue or CSF epigenetic/protein measures that do not track with blood changes; (c) replication studies showing methylation directionality inconsistent with current reports.
Practical next steps to strengthen the evidence
Run a multi-center RCT (active control) with pre-specified primary molecular endpoints (BDNF, cortisol, and a limited methylation panel) and sufficient power to detect reported effect sizes (e.g., BDNF Δ≈5 ng/mL; sample-size calc needed).
Perform cell-type deconvolution and technical replication (bisulfite sequencing) to exclude blood cell–composition confounding for methylation changes.
Share raw methylation array data (de-identified) for independent differential-methylation reanalysis with strict privacy controls.
Implement longitudinal sampling (baseline, short-term retreat, long-term follow-up) and include functional outcomes (cognitive testing, AD biomarkers) when making claims about neuroprotection.
All claims above are tied directly to the primary studies cited below; limitations, potential confounders, and replication gaps are emphasized. For deeper, reproducible reanalysis (e.g., meta-analysis, power calculations, or raw-array reprocessing), press "Run AI Scientist Analysis" to launch an iterative bioinformatics agent.
Preparing per-subject methylation and biomarker effect-size calculations, cell-type deconvolution, and meta-analysis inputs from the cited studies to test replication and compute required sample sizes.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
Meditation directly reverses brain DNA methylation in AD-vulnerable neurons — unlikely because current evidence is limited to peripheral blood and lacks direct brain/CSF validation.
All observed molecular changes are purely placebo/Hawthorne effects — partly falsified by randomized YMLI biomarker changes, but residual expectation effects remain possible without participant blinding.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion